Clinical Trial Update: Dosage and PD Study of Eftrenonacog-alfa

View source ↗

Summary

Completed clinical trial update evaluating dosage and pharmacodynamics of Alprolix (eftrenonacog-alfa) for hemophilia B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Alprolix (eftrenonacog alfa)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Severe Haemophilia B | Status: COMPLETED